secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2026-10-15T21:00:14+00:00
Accession:  0001193125-26-423002
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Olema director Gorjan Hrustanovic resigns; Prakash Raman named to two board committees
--------------------------------------------------------------------------------

- Dr. Gorjan Hrustanovic notified Olema on October 12, 2026 of his resignation from the Board of Directors, effective October 14, 2026.
- Hrustanovic also resigned from the Board's Compensation Committee and Science and Technology Committee; the filing states no disagreement with the company prompted the exit.
- On October 15, 2026, the Board appointed Dr. Prakash Raman to the Compensation Committee and the Science and Technology Committee, effective the same day.
- No permanent replacement for Hrustanovic's full board seat was disclosed in the filing; Sean Bohen, M.D., Ph.D., remains President and CEO.
- Committee reshuffle only — no financial terms, equity awards or severance arrangements were described.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/0001193125-26-423002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/olma-20261012.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-423002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer